ClinicalTrials.gov
ClinicalTrials.gov Menu

RTA 744 Injection in Patients With Leptomeningeal Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00512460
Recruitment Status : Terminated (Study was closed due to loss of industry sponsorship)
First Posted : August 7, 2007
Last Update Posted : May 16, 2016
Sponsor:
Collaborator:
Reata Pharmaceuticals, Inc.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2010
  Actual Study Completion Date : March 2010